- Home
- ETON vs KFII Comparison
ETON vs KFII Comparison
Compare ETON & KFII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- KFII
- Stock Information
- Founded
- ETON 2017
- KFII 2024
- Country
- ETON United States
- KFII United States
- Employees
- ETON N/A
- KFII N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- KFII
- Sector
- ETON Health Care
- KFII
- Exchange
- ETON Nasdaq
- KFII NYSE
- Market Cap
- ETON 428.5M
- KFII 393.3M
- IPO Year
- ETON 2018
- KFII 2025
- Fundamental
- Price
- ETON $13.75
- KFII $10.18
- Analyst Decision
- ETON Strong Buy
- KFII
- Analyst Count
- ETON 3
- KFII 0
- Target Price
- ETON $29.67
- KFII N/A
- AVG Volume (30 Days)
- ETON 457.7K
- KFII 97.7K
- Earning Date
- ETON 08-07-2025
- KFII 01-01-0001
- Dividend Yield
- ETON N/A
- KFII N/A
- EPS Growth
- ETON N/A
- KFII N/A
- EPS
- ETON N/A
- KFII N/A
- Revenue
- ETON $48,327,000.00
- KFII N/A
- Revenue This Year
- ETON $103.21
- KFII N/A
- Revenue Next Year
- ETON $51.34
- KFII N/A
- P/E Ratio
- ETON N/A
- KFII N/A
- Revenue Growth
- ETON 40.88
- KFII N/A
- 52 Week Low
- ETON $3.19
- KFII $9.90
- 52 Week High
- ETON $21.48
- KFII $10.18
- Technical
- Relative Strength Index (RSI)
- ETON 26.60
- KFII N/A
- Support Level
- ETON $13.09
- KFII N/A
- Resistance Level
- ETON $14.18
- KFII N/A
- Average True Range (ATR)
- ETON 0.78
- KFII 0.00
- MACD
- ETON -0.23
- KFII 0.00
- Stochastic Oscillator
- ETON 8.78
- KFII 0.00
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About KFII K&F GROWTH ACQUISITION CORP II
K&F Growth Acquisition Corp II is a special purpose acquisition company.